Changes in sexual functioning in women of reproductive age with infertility and diminished ovarian reserve

Gavisova AA, Stenyaeva NN, Gardanova ZR, Nazarenko TA, Dolgushina NV
About authors

Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia

Correspondence should be addressed: Alla A. Gavisova
Akademika Oparina, 4, Moscow, 117997; ur.ay@allaivag

About paper

Author contribution: Gavisova AA — analysis, manuscript writing, final approval; Gavisova AA, Dolgushina NV — study design; Stenyaeva NN, Gardanova ZR, Nazarenko TA, Dolgushina NV — review.

Compliance with ethical standards: the study was approved by the ethical review board at the Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology (protocol № 2 of 07 February 2019).

Received: 2022-08-26 Accepted: 2022-09-13 Published online: 2022-09-23
  1. Kirschner AA, Bardin CW. Androgen production and metabolism in normal and virilized women. Metabolism. 1972; 21 (7): 667– 88. DOI: 10.1016/0026-0495(72)90090-x.
  2. Lenie S, Smitz J. Functional AR signaling is evident in an in vitro mouse follicle culture bioassay that encompasses most stages of folliculogenesis. Biol Reprod. 2009; 80 (4): 685–95. DOI: 10.1095/ biolreprod.107.067280. Epub 2008 Dec 10. PMID: 19074005.
  3. Bramen JE, Hranilovich JA, Dahl RE, Chen J, Rosso C, Forbes EE, et al. Sex matters during adolescence: testosterone-related cortical thickness maturation differs between boys and girls. PLoS One. 2012; 7 (3): e33850. DOI: 10.1371/journal.pone.0033850. Epub 2012 Mar 29. PMID: 22479458; PMCID: PMC3315517.
  4. Cappelletti M, Wallen K. Increasing women's sexual desire: the comparative effectiveness of estrogens and androgens. Horm Behav. 2016; 78: 178–93. DOI: 10.1016/j. yhbeh.2015.11.003. Epub 2015 Nov 14.
  5. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000; 26 (2): 191–208. DOI: 10.1080/009262300278597. PMID: 10782451.
  6. Stenyaeva NN, Khritinin DF, Chausov AA. Ginekologicheskie zabolevaniya kak prediktory zhenskoj seksual'noj disfunkcii. Ginekologiya. 2021: 2. Russian.
  7. Poletti A, Martini L. Androgen-activating enzymes in the central nervous system. J Steroid Biochem Mol Biol. 1999; 69 (1–6): 117– 22. DOI: 10.1016/s0960-0760(98)00150-2. PMID: 10418985.
  8. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999; 281: 537–44.
  9. Goncharov NP, Dedov II, Gavisova AA, Sukhikh GT. Ehndokrinnaya sistema cheloveka v razlichnye periody ego zhizni. M.: Izdatel'stvo Adamant, 2020. Russian.
  10. Graziottin A, Serafini A, Palacios S. Aetiology, diagnostic algorithms and prognosis of female sexual dysfunction. Maturitas. 2009; 63 (2): 128–34. DOI: 10.1016/j.maturitas.2009.04.007. Epub 2009 Jun 2. PMID: 19493639.
  11. Bemesderfer S. A revised psychoanalytic view of menopause. J Am Psychoanal Assoc. 1996; 44 Suppl: 351–69. PMID: 9170070.
  12. Worboys S, Kotsopoulos D, Teede H, McGrath B, Davis SR. Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen. J Clin Endocrinol Metab. 2001; 86 (1): 158–61. DOI: 10.1210/ jcem.86.1.7103. PMID: 11231994.
  13. Nastri CO, Lara LA, Ferriani RA, Rosa-E-Silva AC, Figueiredo JB, Martins WP. Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2013; (6): CD009672. DOI: 10.1002/14651858.CD009672.pub2. PMID: 23737033.
  14. Davis SR, Goldstat R, Papalia MA, Shah S, Kulkarni J, Donath S, et al. Effects of aromatase inhibition on sexual function and wellbeing in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial. Menopause. 2006; 13 (1): 37–45. DOI: 10.1097/01.gme.0000168061.32917.83. PMID: 16607097.
  15. Bachmann G, Bancrofti J, Braunstein G, Burger H, Davis S, Dennesrtein L. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril. 2002; 77 (4): 660–5. DOI: 10.1016/ s0015-0282(02)02969-2.